BMY
2025Q1BMOBristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS1.50
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move2.1%
IV front—
P/C full—
P/C front—
Features as of2025-04-23
Run-up
Close—
Ret 5d-2.9%
Ret 10d-8.6%
Ret 20d-18.0%
Ret 30d-21.1%
Actual EPS
1.80Beat
Estimated EPS1.50
Actual revenue
11.2B
Surprise %+20.0%
Beat / missBeat
Beat streak 44
Beat streak 84
Reaction
1-day stock reaction+1.6%
Implied vs actual
Implied 2.1%Actual 1.2%
Gap reaction-1.2%
Day result+0.3%
Next-day upYes
Realized / IV0.58×
Post tape
Post 5d+1.9%
Post 10d-3.7%
Post volume20.6M
Vol ×10d1.22×
Vol ×20d1.42×
Post range4.0%